Selected Publications
Garfall A, Dancy E, Cohen A, Wang WH, Frai J, Suhoski M, Levine B, Siegel D, Stadtmauer E, Vogl D, Waxman A, Rapoport A, Milone M, June C, Melenhorst J: T cell phenotypes associated with effective CAR T cell therapy in post-induction versus relapsed multiple myeloma Blood Advances : 2019.
Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D.: Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma Journal of Clinical Oncology 37 (22): 1946-1955,2019.
Demissei BG, Finkelman BS, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan HK, Narayan V, Waxman AJ, Domchek SM, DeMichele A, Shah P, Clark AS, Bradbury AR, Carver JR, Upshaw J, Armenian SH, Liu P, Ky B.: Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy. Cancer 125 (16): 2762-2771,2019.
Demissei BG, Finkelman BS, Hubbard RA, Smith AM, Narayan HK, Narayan V, Shah P, Waxman AJ, Domchek SM, Ky B.: Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy. Journal of the American College of Cardiology 73 (2): 248-249,2019.
Vajravelu RK, Mamtani R, Scott FI, Waxman A, Lewis JD.: Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study. Gastroenterology 155 (5): 1416-1427,2018.
Waxman AJ, Clasen S, Hwang WT, Garfall A, Vogl DT, Carver J, O'Quinn R, Cohen AD, Stadtmauer EA, Ky B, Weiss BM.: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol. 4 (3): e174519,2018.
Cornell RF, Ky B, Weiss BM, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell S, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Innis-Shelton R, Waxman A, Lenihan D.: Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma American Society of Hematology Annual Meeting, Atlanta, GA : 2017.
Waxman AJ, Clasen SC.: Managing Cardiovascular(CV)Toxicity in a Patient Receiving Therapy for Relapsed Myeloma." Leukemia and Lymphoma Society: Myeloma Rounds, Philadelphia, PA : 2017.
Waxman AJ, Clasen S, Garfall AL, Carver JR, Vogl DT, O'Quinn R, Cohen AD, Stadtmauer ES, Ky B, Weiss, BM.: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis American Society of Clinical Oncology Annual Meeting, Chicago, IL : 2017.
Yui JC, Van Keer J, Weiss BM, Waxman AJ, Palmer MB, D'Agati VD, Kastritis E, Dimopoulos MA, Vij R, Bansal D, Dingli D, Nasr SH, Leung N.: Proteasome inhibitor associated thrombotic microangiopathy. Am J Hematol 91 (9): 2016.
Academic Contact Information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavilion
Room #12-153
Philadelphia, PA 19104
Philadelphia,
PA
19104
Patient appointments: 800-789-7366